Regeneron Pharmaceuticals
REGN
REGN
632 hedge funds and large institutions have $20.4B invested in Regeneron Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 250 increasing their positions, 215 reducing their positions, and 79 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
11% less call options, than puts
Call options by funds: $497M | Put options by funds: $560M
12% less capital invested
Capital invested by funds: $23.1B → $20.4B (-$2.69B)
30% less first-time investments, than exits
New positions opened: 55 | Existing positions closed: 79
Holders
632
Holding in Top 10
5
Calls
$497M
Puts
$560M
Top Buyers
| 1 | +$166M | |
| 2 | +$86.4M | |
| 3 | +$62.9M | |
| 4 |
BlackRock
New York
|
+$59.3M |
| 5 |
Two Sigma Investments
New York
|
+$35.3M |
Top Sellers
| 1 | -$128M | |
| 2 | -$126M | |
| 3 | -$116M | |
| 4 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
-$66.7M |
| 5 |
Goldman Sachs
New York
|
-$45.3M |